Swedish healthtech startup Tandem Health is putting artificial intelligence at the centre of a much bigger healthcare ambition after raising $100 million in Series B funding, giving the company fresh firepower to expand across Europe and move beyond medical documentation into a broader AI operating system for clinics.
$100M Series B
The funding round was led by the EU backed Scaleup Europe Fund, a €5 billion investment vehicle managed by EQT. Existing investors Kinnevik, Northzone, Amino Collective and Visionaries also participated in the round.
The financing follows Tandem Health’s $50 million Series A announced in 2025 and brings the company’s total funding to approximately $160 million. The company has not disclosed the valuation attached to the latest round.
The investment also represents the Scaleup Europe Fund’s first investment in healthtech. The fund has previously backed European technology companies including French AI company Mistral and Finnish satellite company Iceye.
From Medical Notes to Clinical Workflows
Tandem Health initially built its business around a relatively focused problem, reducing the administrative burden on clinicians by automatically generating medical notes during patient consultations.
Its AI Medical Assistant uses large language models to capture conversations and create structured clinical documentation, which clinicians can review and approve before it becomes part of the patient record.
The company has since expanded the platform beyond note taking. Its technology now supports activities before, during and after consultations, including patient preparation, referrals, clinical decision support, documentation and coding.
Tandem says its platform is now used by 10,000 care organisations across 14 European markets. Its UK operations represent its largest market by user numbers, with the company also building a presence across several other European healthcare systems.
Building an AI Native Clinic
The company’s next ambition is considerably broader. Tandem wants to evolve from an AI medical assistant into what it calls an AI native clinic operating system.
The planned platform is designed to connect different stages of the clinical workflow rather than treating individual AI features as separate tools. Tandem’s roadmap includes managing patient flows and enabling AI agents to handle additional clinical and administrative tasks.
The company has already been expanding its integrations with electronic health record systems. Its platform supports more than 100 EHR systems, including major systems such as Epic and Oracle Health, helping clinics introduce AI without replacing the infrastructure they already use.
Evidence of Clinical Impact
Reducing administrative work remains a central part of Tandem’s value proposition.
The company says peer reviewed research has found that clinicians using Tandem report a 29 percent reduction in time spent on administrative tasks, alongside a 30 percent improvement in job satisfaction and a 30 percent reduction in administrative stress.
The technology is also being developed with clinical oversight. Tandem says its AI generated documentation remains subject to clinician review and approval, while its services are designed as decision support rather than replacements for professional medical judgement.
Tandem has continued adding capabilities during 2026. Its Clinical Decision Support product became available to selected customers in Europe and is certified as a Class IIa medical device under the EU Medical Device Regulation.
Scaling Across Europe
The new capital will primarily support European expansion, customer growth and continued product development. Tandem employs around 170 people and plans to build its organisation as it expands its footprint.
For the company, Europe is not simply a geographic market but a central part of its strategy. Healthcare systems across the continent are highly fragmented, with different languages, regulations, clinical workflows and technology infrastructures.
Tandem CEO and co founder Lukas Saari said the company was created to provide an alternative to healthcare AI developed elsewhere, arguing that Europe should help set the standard for how artificial intelligence enters healthcare.
The latest funding gives Tandem the resources to pursue that ambition at a significantly larger scale, as it attempts to turn an AI tool that saves clinicians time into a broader technology layer connecting the modern European clinic.